Less meat, more plants: top US heart body’s diet advice at odds with MahaAmerican Heart Association bucks Trump administration line to suggest prioritizing plant-based protein over meat In contrast to the federal government’s recommendation of use of beef tallow and consumption of red meat, the AHA pushed for plant-based proteins such as legumes, nuts and seeds. Photograph: Allen J Schaben/Los Angeles Times/Getty Images The American Heart Association’s new nutrition guidance, released on Tuesday, emphasizes a dietary pattern rich in vegetables, fruits and whole grains, prioritizing plant-based protein over meat. It also suggests limiting the use of sugar, salt and ultra-processed foods and replacing full fat dairy with non-fat and low-fat dairy. Donald Trump earlier this year announced a new slate of dietary guidelines that recommended Americans eat more protein from both animal and plant sources, and encouraged the consumption of full-fat dairy. In contrast to the federal government’s recommendation of use of beef tallow and consumption of red meat, the AHA is pushing for plant-based proteins such as legumes, nuts and seeds, choosing low-fat or fat-free dairy, and, when consuming red meat, selecting lean cuts, avoiding processed forms and keeping portions small. The Trump administration and health secretary Robert F Kennedy Jr’s push to “Make America healthy again” has focused on the removal of synthetic dyes, other chemical ingredients, ultra-processed foods, consumption of less sugar and seed oils. The AHA also suggests Americans choose sources of unsaturated fats, avoid ultraprocessed foods and minimize intake of added sugars in beverages and foods. The organization recommended Americans to prepare foods with minimal or no salt, and limit the intake of alcohol. The guidance also recommended children can and should begin following a heart-healthy dietary pattern starting at one year old. The AHA’s guidance was aligned with the US Food and Drug Administration’s dietary guidelines on major issues, a spokesperson from the FDA said, adding they looked forward to working collaboratively with AHA. The AHA, which is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke, releases dietary guidance about every five years to promote cardiovascular health. ARTICLE SOURCE: https://www.theguardian.com/us-news/2026/apr/01/american-heart-association-dietary-guidelines-maha
Thousands Sue Weight Loss Drug Manufacturers With Serious Harm Allegations
By Anthony Yates
Thousands of people have come forward alleging serious harm caused by GLP-1 weight loss drugs. Those products include Ozempic, Wegovy, and Mounjaro.
According to a report by USA Today, at least 4,400 people have filed lawsuits since the first was filed in 2023. Those suits are now part of a consolidated federal and state litigation and target two drugmakers: Novo Nordisk, which manufactures Ozempic, and Eli Lilly, which makes Trulicity, Mounjaro, and Zepbound. The companies reportedly said they refute the allegations and will defend the safety of their products.
The USA Today report focuses on three troubling cases in the growing lawsuit. 63-year-old Todd Engel was using Ozempic to manage his diabetes. However, he told the outlet that he lost vision in one eye after using the drug for four months. His medication reportedly never came up as a potential cause of his sight loss, and he lost vision in his other eye months later.
72-year-old JoHelen McClain reportedly used Wegovy in November 2023, aiming to shed a few pounds. In March 2024, she heard a noise like a "balloon popping," which she later discovered was the sound of her colon rupturing.
USA Today also interviewed Mark Smith. He told the outlet that his wife, 62-year-old Robin Smith, was taking Mounjaro for weight loss. She reportedly visited the hospital twice for vomiting. Her doctor suggested she stop using the drug, but her problems persisted. Days later, doctors diagnosed her with Wernicke's encephalopathy, which the outlet explains is a neurological condition caused by a lack of thiamine or Vitamin B1. It's often linked to malnutrition.
The outlet points out that an estimated 12% of Americans use GLP-1 weight-loss drugs and that the plaintiff's account for a small percentage of users. USA Today also cites a 2024 court filing by the two drug companies.
They explain that the known risks are reflected in FDA-approved labeling, which the FDA has reviewed more than 40 times. USA Today details a Gallup Study, which claims that the usage of GLP-1 drugs doubled between 2024 and 2025.Chief of Research and Development at the St. Louis Veterans Affairs Health Care System, Ziyad Al-Aly, reportedly stated that no medicine is risk-free. However, he believes the benefits outweigh the risks for most patients. Legal challenges are expected to take several years.
ARTICLE SOURCE: https://screenrant.com/thousands-sue-weight-loss-drug-manufacturers/
Subscribe to Carnivore Talk on YouTube | Be our guest on the channel | Leave me a voicemail, yo!